Company Overview - Catheter Precision Inc. is a U.S.-based medical device company focused on developing advanced products for the cardiac electrophysiology market [1][4] - The company is entering the commercial phase of its mission to deliver long-term value to shareholders and the healthcare sector [3] Strategic Partnership - Catheter Precision has engaged PCG Advisory to enhance investor outreach and communication efforts [1][2] - The partnership aims to strengthen engagement with institutional and retail investors and effectively communicate the company's strategic vision [2][3] Product Focus - The company is promoting its innovative technologies, LockeT and VIVO™, which address challenges in electrophysiology and vascular closure [2][3] - These technologies are designed to improve procedural efficiency, reduce complications, and enhance patient care [3] Market Potential - The electrophysiology market is projected to reach $15.1 billion by 2028, driven by increasing demand for ventricular ablation and vascular closure solutions [3]
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy